SCHEMBL22857366

SCHEMBL22857366

COc1ccc(C2CCC(=O)CC2)c2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.45
PDE4B Q07343 2/20 0.45
PDE4C Q08493 2/20 0.45
PDE4D Q08499 2/20 0.45
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
USP2 O75604 1/20 0.42
S100A4 P26447 1/20 0.42
IDO1 P14902 1/20 0.42
PLK1 P53350 1/20 0.42
EP300 Q09472 1/20 0.41
KAT8 Q9H7Z6 1/20 0.41
HTR2C P28335 2/20 0.41
ALDH1A1 P00352 1/20 0.40
POLL Q9UGP5 1/20 0.39
IMPDH2 P12268 1/20 0.39
IMPDH1 P20839 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27805556 0.87 IDO1 (0.50) KMT2AMEN1IDO1PLK1EP300
SCHEMBL28705020 0.82 IDO1 (0.46) KMT2AMEN1IDO1PLK1EP300
SCHEMBL29496823 0.81 TP53 (0.46) KMT2AMEN1USP2S100A4IDO1
SCHEMBL29487580 0.80 HTR2C (0.62) KMT2AMEN1USP2HTR2CPOLL
SCHEMBL5290305 0.80 HTR2C (0.62) KMT2AMEN1USP2HTR2CPOLL
SCHEMBL24101960 0.79 NPC1 (0.46) KMT2AMEN1IDO1PLK1EP300
SCHEMBL30735498 0.79 HTR2C (0.66) HTR2C
SCHEMBL19284730 0.79 HTR2C (0.66) HTR2C
SCHEMBL28712890 0.79 IMPDH2 (0.44) KMT2AMEN1IDO1PLK1EP300
Hydrochloric Acid SCHEMBL28697686 0.78 IMPDH2 (0.43) KMT2AMEN1IDO1PLK1EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109952300-B 5-or 8-substituted imidazo [1,5-a ] pyridines 百济神州有限公司 2022-01-18 CN disclosed
US-10882856-B2 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases BEIGENE, LTD. (KY) 2021-01-05 US disclosed
US-10882856-B2 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases BEIGENE, LTD. (KY) 2021-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10882856-B2 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases IDO1, TPH1, IDO2 PDE4A 757/4885PDE4B 1001/4885PDE4C 1449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.